REBECA trial: a new piece of the evidence for bevacizumab in platinum-resistant recurrent ovarian cancer
Transl Cancer Res
.
2020 Feb;9(2):402-404.
doi: 10.21037/tcr.2019.12.83.
Authors
Daniele Lavacchi
1
,
Sara Fancelli
1
,
Marta Rita Gatta Michelet
1
,
Martina Catalano
1
,
Giandomenico Roviello
2
Affiliations
1
School of Human Health Sciences, University of Florence, Florence, Italy.
2
Department of Health Sciences, University of Florence, Florence, Italy.
PMID:
35117383
PMCID:
PMC8798534
DOI:
10.21037/tcr.2019.12.83
No abstract available
Publication types
Editorial
Comment